Logo image of CE

CELANESE CORP (CE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CE - US1508701034 - Common Stock

44.23 USD
-2.71 (-5.77%)
Last: 1/20/2026, 8:04:00 PM
44.23 USD
0 (0%)
After Hours: 1/20/2026, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CE. CE was compared to 82 industry peers in the Chemicals industry. Both the profitability and financial health of CE have multiple concerns. CE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CE had positive earnings in the past year.
  • CE had a positive operating cash flow in the past year.
  • Of the past 5 years CE 4 years were profitable.
  • Each year in the past 5 years CE had a positive operating cash flow.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -13.95%, CE is doing worse than 80.49% of the companies in the same industry.
  • With a Return On Equity value of -78.22%, CE is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
  • CE has a Return On Invested Capital of 3.60%. This is comparable to the rest of the industry: CE outperforms 50.00% of its industry peers.
  • CE had an Average Return On Invested Capital over the past 3 years of 4.41%. This is in line with the industry average of 6.11%.
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROIC 3.6%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • CE has a Operating Margin (8.72%) which is in line with its industry peers.
  • CE's Operating Margin has declined in the last couple of years.
  • CE's Gross Margin of 21.33% is on the low side compared to the rest of the industry. CE is outperformed by 63.41% of its industry peers.
  • In the last couple of years the Gross Margin of CE has declined.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 21.33%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CE is destroying value.
  • The number of shares outstanding for CE has been increased compared to 1 year ago.
  • CE has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CE has a worse debt to assets ratio.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • CE has an Altman-Z score of 1.48. This is a bad value and indicates that CE is not financially healthy and even has some risk of bankruptcy.
  • CE has a Altman-Z score of 1.48. This is in the lower half of the industry: CE underperforms 64.63% of its industry peers.
  • CE has a debt to FCF ratio of 12.55. This is a negative value and a sign of low solvency as CE would need 12.55 years to pay back of all of its debts.
  • CE has a Debt to FCF ratio (12.55) which is in line with its industry peers.
  • A Debt/Equity ratio of 2.99 is on the high side and indicates that CE has dependencies on debt financing.
  • CE has a worse Debt to Equity ratio (2.99) than 86.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Altman-Z 1.48
ROIC/WACC0.49
WACC7.35%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • CE has a Current Ratio of 1.63. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CE (1.63) is worse than 63.41% of its industry peers.
  • CE has a Quick Ratio of 1.04. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
  • CE's Quick ratio of 1.04 is on the low side compared to the rest of the industry. CE is outperformed by 63.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.04
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

  • The earnings per share for CE have decreased strongly by -47.48% in the last year.
  • The Earnings Per Share has been decreasing by -2.59% on average over the past years.
  • CE shows a decrease in Revenue. In the last year, the revenue decreased by -7.34%.
  • Measured over the past years, CE shows a quite strong growth in Revenue. The Revenue has been growing by 10.30% on average per year.
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%

3.2 Future

  • CE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.78% yearly.
  • The Revenue is expected to decrease by -0.25% on average over the next years.
EPS Next Y-47.42%
EPS Next 2Y-18.27%
EPS Next 3Y-5.94%
EPS Next 5Y3.78%
Revenue Next Year-6.73%
Revenue Next 2Y-3.36%
Revenue Next 3Y-1.24%
Revenue Next 5Y-0.25%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.21, which indicates a very decent valuation of CE.
  • 89.02% of the companies in the same industry are more expensive than CE, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.94, CE is valued rather cheaply.
  • CE is valuated cheaply with a Price/Forward Earnings ratio of 7.93.
  • Based on the Price/Forward Earnings ratio, CE is valued cheaply inside the industry as 91.46% of the companies are valued more expensively.
  • CE is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.21
Fwd PE 7.93
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CE is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, CE is valued cheaply inside the industry as 95.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.73
EV/EBITDA 10.11
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • A cheap valuation may be justified as CE's earnings are expected to decrease with -5.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.27%
EPS Next 3Y-5.94%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.25%, CE is not a good candidate for dividend investing.
  • CE's Dividend Yield is slightly below the industry average, which is at 2.28.
  • Compared to an average S&P500 Dividend Yield of 1.83, CE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of CE has a limited annual growth rate of 3.06%.
  • CE has paid a dividend for at least 10 years, which is a reliable track record.
  • CE has decreased its dividend recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of CE are negative and hence is the payout ratio. CE will probably not be able to sustain this dividend level.
  • The dividend of CE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-2.78%
EPS Next 2Y-18.27%
EPS Next 3Y-5.94%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

CELANESE CORP

NYSE:CE (1/20/2026, 8:04:00 PM)

After market: 44.23 0 (0%)

44.23

-2.71 (-5.77%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)02-17
Inst Owners103.64%
Inst Owner Change0.47%
Ins Owners0.29%
Ins Owner Change1.43%
Market Cap4.84B
Revenue(TTM)9.71B
Net Income(TTM)-3.09B
Analysts73.85
Price Target53.13 (20.12%)
Short Float %7.02%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-2.78%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.25%
Min EPS beat(2)-0.14%
Max EPS beat(2)6.64%
EPS beat(4)3
Avg EPS beat(4)17.03%
Min EPS beat(4)-0.14%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.55%
EPS beat(12)6
Avg EPS beat(12)2.25%
EPS beat(16)8
Avg EPS beat(16)2.68%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-6.31%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-6.31%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-4.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.63%
PT rev (1m)-1.77%
PT rev (3m)-4.54%
EPS NQ rev (1m)-0.74%
EPS NQ rev (3m)-15.4%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)-2.24%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-4.32%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE 9.21
Fwd PE 7.93
P/S 0.5
P/FCF 4.73
P/OCF 3.49
P/B 1.22
P/tB N/A
EV/EBITDA 10.11
EPS(TTM)4.8
EY10.85%
EPS(NY)5.58
Fwd EY12.61%
FCF(TTM)9.35
FCFY21.14%
OCF(TTM)12.68
OCFY28.66%
SpS88.68
BVpS36.11
TBVpS-31.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number62.45
Profitability
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROCE 4.59%
ROIC 3.6%
ROICexc 3.9%
ROICexgc 6.84%
OM 8.72%
PM (TTM) N/A
GM 21.33%
FCFM 10.55%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexgc growth 3Y-25.53%
ROICexgc growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Debt/EBITDA 7.29
Cap/Depr 47.03%
Cap/Sales 3.75%
Interest Coverage 250
Cash Conversion 85.63%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.04
Altman-Z 1.48
F-Score4
WACC7.35%
ROIC/WACC0.49
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
EPS Next Y-47.42%
EPS Next 2Y-18.27%
EPS Next 3Y-5.94%
EPS Next 5Y3.78%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%
Revenue Next Year-6.73%
Revenue Next 2Y-3.36%
Revenue Next 3Y-1.24%
Revenue Next 5Y-0.25%
EBIT growth 1Y-23%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year22.66%
EBIT Next 3Y11.82%
EBIT Next 5Y9.04%
FCF growth 1Y-0.29%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-13.79%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%

CELANESE CORP / CE FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CE.


Can you provide the valuation status for CELANESE CORP?

ChartMill assigns a valuation rating of 6 / 10 to CELANESE CORP (CE). This can be considered as Fairly Valued.


Can you provide the profitability details for CELANESE CORP?

CELANESE CORP (CE) has a profitability rating of 3 / 10.


What is the earnings growth outlook for CELANESE CORP?

The Earnings per Share (EPS) of CELANESE CORP (CE) is expected to decline by -47.42% in the next year.


Is the dividend of CELANESE CORP sustainable?

The dividend rating of CELANESE CORP (CE) is 3 / 10 and the dividend payout ratio is -2.78%.